Probiotics
Also called: live cultures, beneficial bacteria, Lactobacillus, Bifidobacterium, Saccharomyces boulardii
Live microorganisms that, when given in adequate amounts, confer a health benefit on the host. Found in fermented foods, dietary supplements and other products. Effects depend on the specific strain.
- Category
- Probiotic
- Forms
- Live bacteria (commonly Lactobacillus-family and Bifidobacterium species) and yeasts such as Saccharomyces boulardii; amounts stated as colony-forming units (CFU)
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-28
Class 1 Well studied in people. ODS cites a meta-analysis of 21 RCTs (4,780 participants) of Saccharomyces boulardii alone for antibiotic-associated diarrhea. Probiotic reviews define the ingredient by strain or pool strains and mixtures, as in a Cochrane review of 39 RCTs of single probiotics and mixtures for eczema. [1]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BPregnancy and infants1 topic
XSkin and hair1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Antibiotic-associated diarrhea | B | A 2015 meta-analysis of 21 trials (4,780 participants) found S. boulardii lowered antibiotic-associated diarrhea from 18.7% to 8.5% versus placebo or no treatment (RR 0.47, 95% CI 0.38 to 0.57); in adults, from 17.4% to 8.2%. [3] |
| C. difficile diarrhea during antibiotic use | B | A 2017 analysis of 31 studies (8,672 patients, mostly hospitalized) concluded with moderate certainty that probiotics can reduce risk; the best types, doses and durations are uncertain. [2] |
| Necrotizing enterocolitis in preterm infants | B | An AGA 2020 review (63 trials, 15,712 infants) found specific Lactobacillus/Bifidobacterium combinations reduced severe disease and mortality, but a 2023 Cochrane review called evidence for infants under 32 weeks or 1,500 g inconclusive. [1] |
| Irritable bowel syndrome symptoms | C | A 2018 review of 53 studies (5,545 participants) found possible benefits on global symptoms and pain, but no definite conclusions or identification of which strains help. [2] |
| Treatment of atopic dermatitis (eczema) | X | A Cochrane review (39 RCTs, 2,599 participants) found differences that were not clinically significant and did not support probiotics for eczema treatment. [1] |
| Acute infectious diarrhea in children | X | A 2020 Cochrane review (82 RCTs) reported shorter illness, but low-bias studies showed no difference, and two large emergency-department trials, one of LGG and one of an L. rhamnosus R0011 plus L. helveticus R0052 combination, found the probiotics no better than placebo. [1] |
Main constituents: Common genera: Bifidobacterium, Saccharomyces, Streptococcus, Enterococcus, Escherichia, Bacillus and the family Lactobacillaceae [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Many supplements contain 1 to 10 billion CFU per dose; some contain 50 billion CFU or more. A higher CFU count does not necessarily mean greater effectiveness. [1]
- Antibiotic-associated diarrhea in children: LGG at 1-2 x 10^10 CFU/day was studied; starting within 2 days of the first antibiotic dose worked better. [1]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications74 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- FDA (2023): giving probiotics to preterm infants may cause infection or invasive, potentially fatal disease; FDA cited one infant death and more than two dozen other adverse events. [1]
- Bacteremia, fungemia and severe infections have been reported, mostly in severely ill or immunocompromised patients; in one ICU study, 6 of 522 LGG recipients developed LGG bacteremia. [1]
- Possible harms include infections, production of harmful substances by the microorganisms, and transfer of antibiotic resistance genes to other gut microorganisms. [2]
- In healthy people side effects are usually minor, such as gas. [1]
Identity, quality and standardization
- Labels must list total microorganism weight (live and dead cells), which does not reflect viable counts; CFU may be listed voluntarily, and experts advise using the CFU count at the end of shelf life. [1]
- Some probiotic products have been reported to contain microorganisms other than those listed on the label; in some instances these contaminants may pose serious health risks. [2]
Regulatory status
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Live microorganisms, often from the family Lactobacillaceae and the genera Bifidobacterium, Saccharomyces, Streptococcus, Enterococcus, Escherichia and Bacillus; effects can be specific to certain strains Live microorganisms (bacteria and yeasts) [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 74 entries naming a Lactobacillus-group or Bifidobacterium microorganism (ingredient name includes Lactobacillus, a genus split from it such as Lactiplantibacillus or Lacticaseibacillus, or Bifidobacterium) (earliest NDI 36 submitted 1998-05-15; most recent NDI 1443 submitted 2025-11-17). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. Six of these entries describe lysates or heat-treated or heat-killed preparations. Two further entries name Saccharomyces boulardii (NDI 316 submitted 2005-02-08; NDI 346 submitted 2005-09-08). [P1]
- FDA (October 26, 2023) warned health care providers that preterm infants given a probiotic product are at risk of invasive, potentially fatal disease or infection, and issued warning letters to two firms. FDA stated it has not approved any probiotic product for use as a drug or biological product in infants of any age. [P7]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each dietary-ingredient component — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants a petition-based exemption under 111.75(a)(1)(ii). [P4]
- Viable count (CFU) through the end of shelf life — ODS: labels need only list total weight of microorganisms (live and dead); probiotics must be consumed alive to have health benefits and can die during their shelf life. [P5]
- Strain identity and screening for microorganisms not listed on the label — NCCIH reports products containing unlisted microorganisms, some posing serious health risks; ODS notes products might not be labeled with the correct strains. [P6]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- Probiotics may transiently colonize the human gut mucosa in highly individualized patterns. [P5]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (list last updated 2026-07-23 per page data; checked 2026-10-29), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- NIH Office of Dietary Supplements. Probiotics: Fact Sheet for Health Professionals (Updated: March 25, 2025), 2025-03-25. ods.od.nih.gov
- NCCIH. Probiotics: What You Need To Know (Last Updated: August 2019), 2019-08. nccih.nih.gov
- U.S. FDA. FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants (press announcement, October 26, 2023), 2023-10-26. fda.gov
Sources
- NIH Office of Dietary Supplements. Probiotics: Fact Sheet for Health Professionals (Updated: March 25, 2025), 2025-03-25. ods.od.nih.gov
- NCCIH. Probiotics: Usefulness and Safety (Last Updated: August 2019), 2019-08. nccih.nih.gov
- Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2015;42(7):793–801 (PMID 26216624), 2015-07-27. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in probiotic: Akkermansia muciniphila (pasteurized) · Bacillus coagulans (Heyndrickxia coagulans) · Bifidobacterium animalis subsp. lactis BB-12 · Escherichia coli Nissle 1917 (EcN) · Lacticaseibacillus paracasei strain Shirota (LcS) · Lacticaseibacillus rhamnosus GG (LGG) · Lactiplantibacillus plantarum 299v · Limosilactobacillus reuteri DSM 17938 · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.